MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1

Life Sciences

Volumn 157, Issue , 2016, Pages 12-18

  Lu, Lin ^a   Qiu, Chunyu ^b   Li, Dongsheng ^a   Bai, Guang ^a   Liang, Jian ^c   Yang, Qing ^a  

^a JINZHOU MEDICAL UNIVERSITY   (China)

^b Department of Ophthalmology Jinzhou Central Hospital   (China)

^c CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Hepatoma cells; High Mobility Group Box 1; Invasion; MicroRNA 505; Proliferation

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; MICRORNA; MICRORNA 505; UNCLASSIFIED DRUG; HMGB1 PROTEIN, HUMAN; MIRN505 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL INVASION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HEPATOCELLULAR CARCINOMA CELL LINE; HEPATOMA CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; LIVER TUMOR; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE; TUMOR INVASION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; HMGB1 PROTEIN; HUMANS; LIVER NEOPLASMS; MICRORNAS; NEOPLASM INVASIVENESS;

EID: 84971575162     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.05.039     Document Type: Article

References (33)

1. Z. Ben Ari, and et al. Oncogenic viruses and hepatocellular carcinoma Clin. Liver Dis. 19 2 2015 341 360
2. D. Pouessel, and et al. Hepatic metastases from carcinomas of unknown primary site Gastroenterol. Clin. Biol. 29 12 2005 1224 1232
3. Forner A et al. Hepatocellular carcinoma. Lancet, 379(9822): 1245-55
4. P. Kaposi-Novak, and et al. Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype J. Clin. Invest. 116 6 2006 1582 1595
5. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2 2004 281 297
6. D.P. Bartel MicroRNAs: target recognition and regulatory functions Cell 136 2 2009 215 233
7. W. Filipowicz, and et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat. Rev. Genet. 9 2 2008 102 114
8. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 11 2006 857 866
9. B. Zhang, and et al. microRNAs as oncogenes and tumor suppressors Dev. Biol. 302 1 2007 1 12
10. H. He, and et al. The role of microRNA genes in papillary thyroid carcinoma Proc. Natl. Acad. Sci. U. S. A. 102 52 2005 19075 19080
11. E.J. Lee, and et al. Expression profiling identifies microRNA signature in pancreatic cancer Int. J. Cancer 120 5 2007 1046 1054
12. A. Tivnan, and et al. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma BMC Cancer 11 2011 33
13. I. Barshack, and et al. Differential diagnosis of hepatocellular carcinoma from metastatic tumors in the liver using microRNA expression Int. J. Biochem. Cell Biol. 42 8 2010 1355 1362
14. R.I. Gregory, and R. Shiekhattar MicroRNA biogenesis and cancer Cancer Res. 65 9 2005 3509 3512
15. L. Lin, and et al. Microarray analysis of microRNA expression in liver cancer tissues and normal control Gene 523 2 2013 158 160
16. X.J. Lin, and et al. A serum microRNA classifier for early detection of hepatocellular carcinoma: a multicentre, retrospective, longitudinal biomarker identification study with a nested case-control study Lancet Oncol. 2015
17. Y. Yamamoto, and et al. An integrative genomic analysis revealed the relevance of microRNA and gene expression for drug-resistance in human breast cancer cells Mol. Cancer 10 2011 135
18. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 29 9 2001 e45
19. J. Yang, and R.A. Weinberg Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis Dev. Cell 14 6 2008 818 829
20. N. Jiang, and et al. Downregulation of miR-432 activates Wnt/beta-catenin signaling and promotes human hepatocellular carcinoma proliferation Oncotarget 6 10 2015 7866 7879
21. I. Kawashima, and et al. Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3 Clin. Case Rep. 3 6 2015 444 447
22. T. Eggert, and et al. Epidemiology of fibrolamellar hepatocellular carcinoma in the USA, 2000-10 Gut 62 11 2013 1667 1668
23. L. Li, and et al. Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4 Gut 64 1 2015 156 167
24. L. Wang, and et al. MicroRNA-215 is upregulated by treatment with Adriamycin and leads to the chemoresistance of hepatocellular carcinoma cells and tissues Mol. Med. Rep. 2015 1(10)
25. W. Yin, and et al. miR-193b acts as a cisplatin sensitizer via the caspase-3-dependent pathway in HCC chemotherapy Oncol. Rep. 34 1 2015 368 374
26. J. Tian, and et al. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis Brit. J. Cancer 81 5 1999 814 821
27. G. Yang, and et al. EMT transcription factors: implication in osteosarcoma Med. Oncol. 30 4 2013 1 5
28. H. Ma, and et al. CCR7 enhances TGF-beta1-induced epithelial-mesenchymal transition and is associated with lymph node metastasis and poor overall survival in gastric cancer Oncotarget 6 2015 6
29. T.H. Wang, and et al. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition Oncotarget 2015
30. S. Xu, and et al. Downregulation of long noncoding RNA MALAT1 induces epithelial-to-mesenchymal transition via the PI3K-AKT pathway in breast cancer Int. J. Clin. Exp. Pathol. 8 5 2015 4881 4891
31. Z. Qin, and et al. MicroRNAs provide feedback regulation of epithelial-mesenchymal transition induced by growth factors J. Cell. Physiol. 2015 (n/a-n/a)
32. L. Wu, and et al. MicroRNAs direct rapid deadenylation of mRNA Proc. Natl. Acad. Sci. U. S. A. 103 11 2006 4034 4039
33. W. Yan, and et al. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases Hepatology 55 6 2012 1863 1875